Sarepta Therapeutics (SRPT) EBIT Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 14,402.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,402.00 |
| Dec 31, 2025 | -2,978.00 |
| Sep 30, 2025 | 3,733.00 |
| Jun 30, 2025 | 11,888.00 |
| Mar 31, 2025 | 16,953.00 |
| Dec 31, 2024 | 11,905.00 |
| Sep 30, 2024 | 2,294.00 |
| Jun 30, 2024 | 11,795.00 |
| Mar 31, 2024 | 11,180.00 |
| Dec 31, 2023 | 76,425.00 |
| Sep 30, 2023 | 60,305.00 |
| Jun 30, 2023 | -6,835.00 |
| Mar 31, 2023 | 83,791.00 |
| Dec 31, 2022 | 16,681.00 |
| Sep 30, 2022 | 6,157.00 |
| Jun 30, 2022 | 19,091.00 |
| Mar 31, 2022 | -30,703.00 |
| Dec 31, 2021 | 7,060.00 |
| Sep 30, 2021 | 7,112.00 |
| Jun 30, 2021 | 2,252.00 |
| Mar 31, 2021 | -5,578.00 |
| Dec 31, 2020 | -71,853.00 |
| Sep 30, 2020 | -50,943.00 |
| Jun 30, 2020 | -35,083.00 |
| Mar 31, 2020 | -65,223.00 |
| Dec 31, 2017 | 16.56 Mn |
| Sep 30, 2017 | 307,999.00 |
| Jun 30, 2017 | 99,102.00 |
| Mar 31, 2017 | 17,248.00 |